Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemung Financial (CHMG) Total Liabilities: 2016-2025

Historic Total Liabilities for Chemung Financial (CHMG) over the last 10 years, with Sep 2025 value amounting to $2.5 billion.

  • Chemung Financial's Total Liabilities fell 4.00% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 4.00%. This contributed to the annual value of $2.6 billion for FY2024, which is 1.81% up from last year.
  • As of Q3 2025, Chemung Financial's Total Liabilities stood at $2.5 billion, which was down 6.35% from $2.6 billion recorded in Q2 2025.
  • Chemung Financial's Total Liabilities' 5-year high stood at $2.6 billion during Q2 2025, with a 5-year trough of $2.2 billion in Q2 2021.
  • Moreover, its 3-year median value for Total Liabilities was $2.6 billion (2024), whereas its average is $2.5 billion.
  • As far as peak fluctuations go, Chemung Financial's Total Liabilities skyrocketed by 36.15% in 2021, and later fell by 4.00% in 2025.
  • Chemung Financial's Total Liabilities (Quarterly) stood at $2.2 billion in 2021, then increased by 12.33% to $2.5 billion in 2022, then increased by 1.46% to $2.5 billion in 2023, then rose by 1.81% to $2.6 billion in 2024, then decreased by 4.00% to $2.5 billion in 2025.
  • Its Total Liabilities was $2.5 billion in Q3 2025, compared to $2.6 billion in Q2 2025 and $2.6 billion in Q1 2025.